GSK said it had undertaken a “full selection process and Jones Lang LaSalle was chosen based on its expertise, capabilities, pricing, and global scope”.
GSK said it had undertaken a “full selection process and Jones Lang LaSalle was chosen based on its expertise, capabilities, pricing, and global scope”.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In